Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Onconova Therapeutics, Inc. - Common Stock (NQ:ONTX)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Apr 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Onconova Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  On Thursday, 116 companies set new 52-week lows. 
Via Benzinga
Onconova Therapeutics's Return On Capital Employed Insights
Via Benzinga
Earnings Scheduled For August 11, 2022
Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million. 
Via Benzinga
Recap: Onconova Therapeutics Q1 Earnings
Onconova Therapeutics (NASDAQ:ONTX) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Earnings Scheduled For May 11, 2022
Companies Reporting Before The Bell • Great Elm Capital (NASDAQ:GECC) is expected to report earnings for its first quarter. 
Via Benzinga
Earnings Scheduled For November 11, 2021
Companies Reporting Before The Bell • NICE (NASDAQ:NICE) is likely to report quarterly earnings at $1.58 per share on revenue of $465.75 million. • Reshape... 
Via Benzinga
Onconova Therapeutics Appoints Drs. Peter Atadja and Trafford Clarke to its Board of Directors
From Onconova Therapeutics, Inc.
Via GlobeNewswire
Onconova Therapeutics to Present at the Upcoming MedInvest Oncology Investor Conference
From Onconova Therapeutics, Inc.
Via GlobeNewswire
Onconova Therapeutics to Present at the Upcoming RHK Capital Disruptive Growth Conference
From Onconova Therapeutics, Inc.
Via GlobeNewswire
Why Fast Radius Shares Plunged Around 48%; Here Are 103 Biggest Movers From Yesterday
Gainers Satixfy Communications Ltd. (NYSE: SATX) shares gained 140.7% to settle at $31.80 on Tuesday. 
Via Benzinga
Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 67 Stocks Moving In Tuesday's Mid-Day Session
Gainers SenesTech, Inc. (NASDAQ: SNES) shares surged 91.7% to $0.2751. SenesTech reported a 1-for-20 reverse stock split. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Azenta (NASDAQ:AZTA) shares rose 32.5% to $61.74 during Tuesday's pre-market session. The company's market cap stands at $4.6 billion. As per the news, the Q4 earnings report came out... 
Via Benzinga
Why PlayAGS Shares Are Trading Lower By Over 15%; Here Are 33 Stocks Moving Premarket
    
Via Benzinga
Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday
Gainers Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) shares surged 113.8% to settle at $20.10 on Monday. Indivior PLC agreed to acquire Opiant Pharmaceuticals for $20.00 per share in cash, plus... 
Via Benzinga
Onconova Therapeutics Announces Plans for a Phase 1/2a Trial of Narazaciclib Combined with Letrozole in Endometrial Cancer, Reports Third Quarter 2022 Financial Results, and Provides a Business Update
From Onconova Therapeutics, Inc.
Via GlobeNewswire
Onconova Therapeutics to Provide Corporate Update and Announce Third Quarter Financial Results on November 14, 2022
Company to host conference call and webcast at 4:30 p.m. Eastern Time on Monday, November 14, 2022 
From Onconova Therapeutics, Inc.
Via GlobeNewswire
Looking Into Onconova Therapeutics's Return On Capital Employed
According to data from Benzinga Pro, during Q2, Onconova Therapeutics's (NASDAQ:ONTX) reported sales totaled $57 thousand. Despite a 2.38% increase in earnings, the company posted a loss of $4.02... 
Via Benzinga
74 Biggest Movers From Yesterday
Gainers 
Via Benzinga
Onconova Therapeutics Earnings Preview
Onconova Therapeutics (NASDAQ:ONTX) is set to give its latest quarterly earnings report on Wednesday, 2022-05-11. Here's what investors need to know before the announcement. Analysts estimate that... 
Via Benzinga
53 Stocks Moving In Thursday's Mid-Day Session
Gainers 
Via Benzinga
Recap: Onconova Therapeutics Q4 Earnings
Onconova Therapeutics (NASDAQ:ONTX) reported its Q4 earnings results on Thursday, March 17, 2022 at 04:00 PM. Here's what investors need to know about the announcement.... 
Via Benzinga
The Daily Biotech Pulse: AbbVie's Rinvoq Gets Label Expansion, AstraZeneca COVID Antibody Cocktail Authorized By UK Regulator, Stealth Touts Positive Data
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Earnings Scheduled For March 17, 2022
Companies Reporting Before The Bell • TransGlobe Energy (NASDAQ:TGA) is estimated to report earnings for its fourth quarter. • Ikena Oncology (NASDAQ:IKNA) is... 
Via Benzinga
Earnings Outlook For Onconova Therapeutics
Onconova Therapeutics (NASDAQ:ONTX) is set to give its latest quarterly earnings report on Thursday, 2022-03-17. Here's what investors need to know before the announcement.... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2022
Upgrades Stifel upgraded the previous rating for Revolution Medicines Inc (NASDAQ:RVMD) from Hold to Buy. For the fourth quarter, Revolution Medicines had an EPS of $0.71,... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Calliditas Therapeutics (NASDAQ: 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers ACADIA Pharmaceuticals (NASDAQ:ACAD) stock rose 18.35% to $22.96 during Tuesday's pre-market session. The company's market cap stands at $3.6 billion.... 
Via Benzinga
Recap: Onconova Therapeutics Q3 Earnings
Onconova Therapeutics (NASDAQ:ONTX) reported its Q3 earnings results on Thursday, November 11, 2021 at 04:00 PM. Here's what investors need to know about the announcement.... 
Via Benzinga
Onconova Therapeutics Earnings Perspective: Return On Capital Employed
Benzinga Pro data, Onconova Therapeutics (NASDAQ:ONTX) reported Q2 sales of $57.00 thousand. Earnings fell to a loss of $4.64 million, resulting in a 13.35% decrease from last... 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.